tiprankstipranks
Advertisement
Advertisement
Polyrizon Ltd trading resumes
PremiumThe FlyPolyrizon Ltd trading resumes
22d ago
Polyrizon files European patent application for Trap & Target platform
Premium
The Fly
Polyrizon files European patent application for Trap & Target platform
23d ago
Polyrizon Files European Patent Application for Trap & Target Intranasal Drug Delivery Platform
Premium
Company Announcements
Polyrizon Files European Patent Application for Trap & Target Intranasal Drug Delivery Platform
23d ago
Polyrizon Taps Global CRO to Run Key Preclinical Safety Studies Ahead of First Clinical Trials
PremiumCompany AnnouncementsPolyrizon Taps Global CRO to Run Key Preclinical Safety Studies Ahead of First Clinical Trials
2M ago
Polyrizon signs agreement with research organization for clinical development
Premium
The Fly
Polyrizon signs agreement with research organization for clinical development
2M ago
Polyrizon Completes GMP Clinical Material for Planned U.S. Intranasal Study
Premium
Company Announcements
Polyrizon Completes GMP Clinical Material for Planned U.S. Intranasal Study
2M ago
Polyrizon intends to acquire a 51% stake in Arrow Aviation
PremiumThe FlyPolyrizon intends to acquire a 51% stake in Arrow Aviation
3M ago
Polyrizon and Clearmind Partner on Intranasal Non-Hallucinogenic Neuroplastogen MEAI
Premium
Company Announcements
Polyrizon and Clearmind Partner on Intranasal Non-Hallucinogenic Neuroplastogen MEAI
3M ago
Clearmind, Polyrizon enter development agreement for intranasal MEAI formulation
Premium
The Fly
Clearmind, Polyrizon enter development agreement for intranasal MEAI formulation
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100